This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Jan Terje Andersen, Ph.D.
Professor, University of Oslo and Group Leader at Oslo University Hospital
Speaker

Profile

Andersen is professor in biomedical innovation and is heading the Laboratory of Adaptive Immunity and Homeostasis, which is a member of PRIMA - a Centre of Excellence in Precision Immunotherapy at University of Oslo and Oslo University Hospital. His laboratory is studying the cellular processes and molecular interplay underlying the functions of the two most abundant proteins in blood, albumin and IgG. By combining structural and biophysical approaches with cellular and in vivo studies, the in-depth knowledge is used in design of novel molecules with improved functions. The laboratory is extensively collaborating with biotech and pharmaceutical companies. Andersen has obtained the Fridtjof Nansen Prize for Early Career Achievements, a Distinguished Innovator Grant from Novo Nordisk Foundation and the University of Oslo Innovation Award. He is an elected member of the Norwegian Academy of Science and Letters and co-founder of the biotech companies Authera AS and Superio Bio AS.

Agenda Sessions

  • The Brambell Receptor – From Biology to Versatile Therapeutic Applications

    09:05
  • Keynote Panel Discussion

    10:50
  • Co-Chairs’ Remarks

    14:20